New research shows that fecal transplants may boost the effectiveness of cancer immunotherapy drugs called PD-1 inhibitors.

Aprea Therapeutics, Inc. (Nasdaq: APRE) has entered into a Material Transfer Agreement (MTA) with MD Anderson Cancer Center ...

Metastatic prostate cancer patients in the Capital Region now have a new treatment option at Ochsner MD Anderson Cancer ...

Aprea Therapeutics (APRE) has entered into a Material Transfer Agreement with MD Anderson Cancer Center. Under the agreement, Aprea will supply ...

MD Anderson Cancer Center researchers reveal that more women are being diagnosed with cervical cancer. However, doctors ...

HOUSTON, Texas (KTRK) -- A report released on Monday by MD Anderson Cancer Center researchers reveals a troubling trend in cervical cancer. After decades of progress, new data shows more women are ...

Aprea Therapeutics Inc. has entered into a material transfer agreement with MD Anderson Cancer Center that will support investigation of APR-1051 as a potential treatment for head and neck squamous ...

Researchers at the University of Texas MD Anderson Cancer Center have developed a novel antibody-toxin conjugate (ATC) ...

A new addition to the Banner MD Anderson Cancer Center campus in Gilbert is providing a respite for cancer patients and their ...

The first patient has been enrolled in the phase 3 PROSTATE-IQ trial being conducted in men with prostate cancer recurrence ...